About Selonterra LLC
Selonterra LLC discovers disease-modifying therapeutics and early, pre-symptomatic diagnostics for Alzheimer's disease (AD). Selonterra built a comprehensive mechanistic model of AD and identified the key proteins causing sporadic AD. Genomic sequence analysis of patients with sporadic AD confirmed the presence of disease-causing mutations in these proteins. These mutated proteins are the targets for Selonterra’s drug discovery and development efforts. Specialties R & D, Drug Discovery
Selonterra LLC Job Openings
Create job profile to receive interview calls for your dream job
Create Job Alert Kick Start! your career with best matching jobs
Location
X